Head & Neck Cancer | Tumor

CURE’s head & neck cancer page is a go-to resource for oncology news and updates in the world of head & neck cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight to the latest treatments and research in head & neck cancer.

FDA Grants Priority Review to Frontline Keytruda to Treat Recurrent, Metastatic HNSCC

February 11th 2019

The Food and Drug Administration granted a priority review to the supplemental biologics license application for Keytruda (pembrolizumab) for the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

Contrary to Previous Studies, Sex May Not Impact Efficacy of Immunotherapy

January 10th 2019

A recent meta-analysis has found no noticeable difference in immunotherapy’s efficacy based on patient sex.

Sweet Serendipity: Cancer Caught on Television

November 27th 2018

Survivor diagnosed with second cancer after surgeon spots a lump on her throat while watching TV.

Immunotherapy May Mean No Chemotherapy for Some With Metastatic Head and Neck Cancer

November 27th 2018

Immunotherapy may lead to a major change in how the treatment of metastatic recurrent head and neck cancer is approached, according to Barbara Burtness, M.D., a professor of medicine at Yale School of Medicine.

Standard Regimen Remains Superior in HPV-positive Oropharyngeal Carcinoma

November 27th 2018

Despite associated toxicities, cisplatin chemotherapy induced superior efficacy compared with a new alternative among patients with HPV-positive oropharyngeal carcinoma.

FDA Approves Larotrectinib for NTRK-Positive Cancers

November 27th 2018

The FDA has granted an accelerated approval to larotrectinib for the treatment of adult and pediatric patients with solid tumors that have an NTRK gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have no satisfactory alternative treatments or that have progressed following treatment.

Social Habits, Cancer Type and Treatment Impact Increased Rates of Opioid Use

November 26th 2018

Patients who received chemotherapy, actively smoked and drank alcohol, and were diagnosed with head and neck cancer reported significantly higher rates of opiate use, according to study results presented at the American Society of Clinical Oncology (ASCO) 2018 Palliative and Supportive Care Symposium.

The Day a Spot Turned Into Cancer

November 26th 2018

SCOTT WIESKAMP KNEW THE spot on his tonsil wasn’t normal.

Advice for Caregivers: It's Okay to Not be Okay Sometimes

November 8th 2018

In this week’s episode of CURE Talks Cancer, we spoke with Jill Kelly – wife of Pro Football Hall of Fame Quarterback Jim Kelly – about his bout with head and neck cancer, and how she copes as a caregiver.

Starting the Conversation: Head and Neck Cancer Survivors Open to Lung Cancer Screening

October 22nd 2018

Patients with head and neck cancer appeared to be receptive to lung cancer screening, according to recent research performed at the University of Iowa Hospitals and Clinics.

Managing Lymphedema: Education is the Best Treatment

October 22nd 2018

To combat the psychological effects from a lymphedema diagnosis, patients need to be equipped with the knowledge and understanding of what the condition is and how it is treated.

LOXO-292 Granted Breakthrough Designation for Thyroid Cancer

October 15th 2018

The Food and Drug Administration has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with advanced RET fusion–positive thyroid cancer who require systemic therapy, have progressed on prior treatment, and have no other acceptable alternative treatment options, according to a statement from Loxo Oncology, the developer of the selective RET inhibitor.

No Sharp Growth Seen in Patients, Survivors of Cancer as Part of Opioid Epidemic

October 2nd 2018

Patients with cancer are 10 times less likely to have an opioid-associated death, according to recent research conducted at Duke University.

Cancer Researchers Win Nobel Prize

October 2nd 2018

Immunotherapy pioneers James P. Allison and Dr. Tasuku Honjo have won the 2018 Nobel Prize in Physiology or Medicine for their research that eventually led to the use of immune checkpoint inhibitors to treat cancer.

The Basics of Head and Neck Cancer

September 20th 2018

In this episode of CURE Talks Cancer, we spoke with Elizabeth Langdon, vice president of strategic communications and development at the Head and Neck Cancer Alliance, about how the organization helps to raise awareness for the prevention, early detection and research of head and neck cancer.

Watch Your Mouth: Oral Mucositis for Cancer Survivors

September 18th 2018

The mouth is also part of the body, and yet, it is only in the past few years that oncologists have begun recommending patients see a dentist before they begin treatment to be sure the teeth and gums are in good shape.

LOXO-292 Granted Breakthrough Therapy Designation for Lung and Thyroid Cancer

September 5th 2018

The FDA has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with RET fusion–positive non–small cell lung cancer (NSCLC) or RET-mutant medullary thyroid cancer (MTC). This designation will expedite the development and review of the drug.

Adjusting to Life With Head and Neck Cancer

August 31st 2018

Head and Neck Cancer: Novel Treatment Approaches

August 31st 2018

Understanding Treatment Options in Head and Neck Cancer

August 31st 2018

Head and Neck Cancer from a Patient's Perspective

August 31st 2018

Head and Neck Cancer: Overcoming Challenges in Treatment

August 31st 2018

Getting a Diagnosis of Head and Neck Cancer

August 31st 2018

An Overview of Head and Neck Cancer

August 31st 2018

Jim Kelly: Never Give Up

August 24th 2018

In this special edition of CURE Talks Cancer, we spoke with NFL Hall of Fame quarterback Jim Kelly about his experience with head and neck cancer, and the humbling experience of winning the Jimmy V award for Perseverance at this year’s ESPY Awards.

The Political Patient

August 23rd 2018

In this week's episode, state senator Eli D. Bebout discusses his two bouts with cancer, and how his health struggles influenced his politics.

Searching for Understanding About RAS Mutations but Capitalizing on What We Know

August 16th 2018

From genetic mutations to treatment behind bars, here's a roundup of our 2018 Summer issue.

Saved by the TV Screen

August 9th 2018

In this week’s episode of CURE Talks Cancer, we spoke with Voigt about how he noticed a lump in a woman’s neck while watching tv and utilized the power of social media to find her – which ultimately led to a thyroid cancer diagnosis.

Working Through Cancer-Related Fatigue

August 6th 2018

About 40 percent of people with cancer are of working age, and typically have a need to maintain their employment throughout their treatment.

Stop, Look and Listen: Surveillance Is an Option for Thyroid Nodules

August 1st 2018

Instead of undergoing surgery for potential cancer, many people with thyroid nodules can safely opt for surveillance.